Clinical Trial Update: Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia [Phase 2, Phase 3]

View source ↗

Summary

The document presents a Phase 2/3 clinical trial evaluating the efficacy and safety of QL0911 for preventing chemotherapy-induced thrombocytopenia; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia

Drugs mentioned

• QL0911

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Chemotherapy-induced Thrombocytopenia | Phase 2, Phase 3 | Status: COMPLETED